# Safety of Dual Blockage of Rennin-angiotensin System in Patients With Advanced Renal Insufficiency

> **NCT00630708** · NA · TERMINATED · sponsor: **Nanfang Hospital, Southern Medical University** · enrollment: 309 (estimated)

## Conditions studied

- Renal Insufficiency, Chronic

## Interventions

- **DRUG:** Benazepril
- **DRUG:** Losartan
- **DRUG:** Benazepril+Losartan

## Key facts

- **NCT ID:** NCT00630708
- **Lead sponsor:** Nanfang Hospital, Southern Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-02
- **Primary completion:** 2014-03
- **Final completion:** 2014-03
- **Target enrollment:** 309 (ESTIMATED)
- **Why stopped:** Significant differences observed between groups.
- **Last updated:** 2016-04-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00630708

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00630708, "Safety of Dual Blockage of Rennin-angiotensin System in Patients With Advanced Renal Insufficiency". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00630708. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*